It follows a decision by U&D last week to waive the condition that certain Chinese regulatory approvals must first be given.

Today will be Endocoal’s last day of trading on the Australian Securities Exchange, with scheme implementation at 38c per share expected on May 7.

Last week, U&D received approval from the Chinese Assets Supervision and Administration Commission to proceed with its proposed scheme of arrangement.

U&D deemed that approval from the National Development and Reform Commission, the Ministry of Commerce and the State Administration of Foreign Exchange were no longer essential for the deal to proceed.

Endocoal said the orders of the court were expected to be lodged with the Australian Securities and Investments Commission today, at which time the scheme would become legally effective.